Updates are available Correction dated 2023-06-13
Click to view Correction: https://doi.org/10.1038/s41467-023-39293-9
-
Authors
Michiels, Emiel https://orcid.org/0000-0001-6065-5576
Roose, Kenny https://orcid.org/0000-0002-5270-4603
Gallardo, Rodrigo https://orcid.org/0000-0003-1584-3564
Khodaparast, Ladan
Khodaparast, Laleh
van der Kant, Rob https://orcid.org/0000-0003-3639-9749
Siemons, Maxime
Houben, Bert https://orcid.org/0000-0002-6750-011X
Ramakers, Meine
Wilkinson, Hannah
Guerreiro, Patricia
Louros, Nikolaos
Kaptein, Suzanne J. F. https://orcid.org/0000-0002-7935-0219
Ibañez, Lorena Itatí https://orcid.org/0000-0002-9393-2004
Smet, Anouk
Baatsen, Pieter
Liu, Shu
Vorberg, Ina https://orcid.org/0000-0003-0583-4015
Bormans, Guy
Neyts, Johan
Saelens, Xavier https://orcid.org/0000-0002-3861-6965
Rousseau, Frederic https://orcid.org/0000-0002-9189-7399
Schymkowitz, Joost https://orcid.org/0000-0003-2020-0168
- License Information
-
More Information
Article History
Received: 21 June 2019
Accepted: 12 May 2020
First Online: 5 June 2020
Change Date: 13 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-39293-9
Competing interests
: The authors declare the following competing interests: J.S. and F.R. are listed as inventors of patents held by their hold institution VIB, covering the peptides described in this manuscript, and which are licensed to Aelin Therapeutics (Leuven, Belgium), of which J.S. and F.R. are the scientific founders. All other authors declare no competing interests.
